outlookNIFTY:

The Nifty opened at 15186.20 with a minor gap up of just 14 points. The index traded sideways and narrow in the first half and recorded its intraday high at 15243.50. In the second half, prices have seen a sharp decline of more than 100 points and recorded its intraday low at 15081. In the last hour of trading, prices have recovered and closed near its opening price at 15163.30 without much change. The Banks and Financials sectors have performed well and closed with a gain while Metal, FMCG and Pharma have closed with losses of more than 1%.

It was a choppy day where prices have moved in both directions but closed near the opening tick. The week that ended was very narrow. Prices have moved within a range of 280 points. A narrow trading range of 200 points is clearly visible at the top of the rally. Boundaries for this range are 15250 as resistance and 15050 as support. Since the trend is still on the upside we will only take trades on the long side. We should look to buy above 15250 or on a dip around 15000. For either trade keep a stop of 150 points and a target of 250 points.

BANK NIFTY:

Bank Nifty opened at 35736.60 without much of a gap. The index first saw a mild decline and recorded its intraday low at 35700.25. Prices then saw a sharp upside move for the whole day and finally closed at 36108.90. PSU and Private Banks both have seen a rally and closed higher. Within the index, in terms of points, ICICI Bank contributed highest while Kotak Bank the lowest. We were long in the index from 35700 with a stop of 35400 and target of 36700. Prices did not touch either the stop or target so our trade remains intact. It was a trend day on the upside in the Bank Index where prices have opened near the low and closed near the high.

A trading range of 1000 points between 35500-36500 has remained intact so far.

Trade AnyTime AnyWhere With Elite Empower Mobile App

Elite-Empower-App-Promotional-Banner-img1

TECHNICAL PICKS

COMPANY  CMP B/S RATIONALE
ICICIBANK 647.60 BUY The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 640 and for the target 660
RELIANCE 2041.8 BUY The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 2020 and for the target 2080.

Get All Your Mutual Fund Portfolio Returns on Your Mobile by Elite Kuber App


Elite-Kuber-Mutual-Fund-Promotional-Banner-img

DERIVATIVE PICKS

STOCK OPTION Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
HDFCBANK 1580 CE BUY 36.75 CMP 26 50 OI increase
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
FINNIFTYW.21.02 Feb 17019.1 0.79 375 3040 ASHOKLEY.21.02 Feb 128.1 -5.39 27.8 49158000
MOTHERSUMI.21.02 Feb 198.45 10.68 31.25 47859000 ITC.21.02 Feb 213.75 -4.89 14.56 137075200
CONCOR.21.02 Feb 545.8 8.64 27.44 7477392 VOLTAS.21.02 Feb 1083.3 -1.67 12.35 4268000
BANKNIFTY.21.02 Feb 36159.45 0.98 16.28 1840100 NATIONALUM.21.02 Feb 49.1 -3.44 9.47 55624000
M&MFIN.21.02 Feb 205.55 4.45 15.89 14816000 ONGC.21.02 Feb 94.45 -2.83 9.2 52999100
                                                                        Short Covering Long Unwinding
Stocks Price Price% OI% OI Stocks Price Price % OI % OI
ACC.21.02 Feb 1771.2 0.09 -5.18 3412000 HINDALCO.21.02 Feb 291.55 -1.77 -3.87 30151600
LICHSGFIN.21.02 Feb 444.45 1.83 -3.95 8180000 IDEA.21.02 Feb 12.35 -4.63 -3.66 889490000
RECLTD.21.02 Feb 147.4 0.58 -3.56 12498000 AUROPHARMA.21.02 Feb 930.1 -0.63 -3.56 9420450
RAMCOCEM.21.02 Feb 959.15 1.48 -3.43 1696600 PFC.21.02 Feb 126.65 -0.86 -3.47 28637800
BANKBARODA.21.02 Feb 77.85 0.97 -3.31 78249600 TATACHEM.21.02 Feb 563.15 -0.2 -3.22 8242000

TOP DELIVERY PERCENTAGE

Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Icici Lombard General In 1494.9 -0.19 555080 464498 67.43 Nifty Bank 36108.9 1 87456
Hdfc Asset Management Co 2998.4 0.64 188575 118494 61.38 Nifty it 26093.8 0.19 87456
Infosys Limited 1309.8 1.33 5797875 2707694 57.94 Nifty Realty 350.6 0.01 87456
Power Grid Corporation o 212.65 -0.51 14099935 6523561 56.56 Nifty 50 15163.3 -0.07 87456
Hindustan Unilever Ltd 2241.55 -0.95 1222094 932003 51.08 Nifty Auto 10912.25 -0.48 87456
Icici Prudential Life In 487.25 -0.81 3278557 3146188 50.96 Nifty Media 1687 -0.96 87456
Hindustan Petroleum Corp 223.85 -1.56 6627798 3318350 50.78 Nifty Energy 17753.05 -1.07 87456
Dabur India Ltd. 534 -0.34 4218265 2276722 50.69 Nifty Pharma 12785.75 -1.11 87456
Indus Towers Limited 245.65 -1.84 3574037 1443153 50.5 Nifty Fmcg 33928.3 -1.55 87456
Petronet Lng Limited 242.2 -0.25 5308401 2290743 49.79 Nifty Metal 3486.25 -1.7 87456

Get Stock Market Recommendation By Our Research Analysts

Market-Research-Promotional-Banner-img5

UPCOMING ECONOMIC DATA

   Domestic                                                                                                                                                  International
INR:  WPI Inflation (YoY) (Jan) on 15th  February, 2021

INR:  Trade Balance (Jan)on 15th February, 2021

•USD :  Core Retail Sales (MoM) (Jan) on 17th February, 2021

•USD :  PPI (MoM) (Jan) on 17th February, 2021

NEWS UPDATES

•Grasim Industries on Friday reported a consolidated profit after tax of Rs 1,384 crore in the third quarter ended December (Q3 FY21), marking a growth of 103 per cent from Rs 680 crore in Q3 FY19. Consolidated revenue for the quarter was up 13 per cent to Rs 20,986 crore from Rs 18,617 crore in the same period while consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) jumped by 52 per cent to Rs 4,476 crore from Rs 2,945 crore.

•Apollo Hospitals on Friday reported a 42 per cent growth in net profit for the quarter ended December 31, 2020 (Q3FY21) at Rs 130 crore. It was Rs 92 crore in the same period last year (Q3FY20) Revenues dropped by around 5 per cent to Rs 2,760 crore compared to Rs 2,911 crore, a year ago. Standalone revenues of the healthcare services division declined by 4 per cent to Rs 1,240.7 crore in the latest December quarter compared to Rs 1296.9 crore in the same quarter last year.

•Commercial vehicle maker Ashok Leyland Ltd. (ALL) sees demand reviving across segments and it is optimistic about the fourth quarter and the next fiscal, the company said on Friday. Vipin Sondhi, the company’s managing director, said the company’s medium and heavy commercial vehicle (MHCV) business grew by 16 per cent in the third quarter compared to the same period last year.

•Equitas Small Finance Bank on Friday said it has launched a FASTag powered truck terminal at Khalapur, in Maharashtra.

Source: Economic Times,  Moneycontrol  ,Business Today, Livemint, Business Standard, Bloomberg Quint

Open Your Demat Account to Invest in Upcoming IPO’sDemat-and-Trading-Account-Promotion-Banner

BOARD MEETING

Company Name Purpose Ex-Date Company Name Purpose Ex-Date
ALORA Quarterly Results 15-Feb-21 MINID Quarterly Results 15-Feb-21
ASYL Quarterly Results 15-Feb-21 PGFOILQ Quarterly Results 15-Feb-21
CDG Quarterly Results 15-Feb-21 RPIL General 15-Feb-21
CONTCHM General 15-Feb-21 SELAN Interim Dividend 15-Feb-21
DIVYAJYQ Quarterly Results 15-Feb-21 SIS Buy Back of Shares 15-Feb-21
EMMSONS Quarterly Results 15-Feb-21 SPICEISL Quarterly Results 15-Feb-21
EUREKAI Quarterly Results;General 15-Feb-21 SSLFINANCE Quarterly Results 15-Feb-21
GEMSPIN Quarterly Results 15-Feb-21 SUJALA Quarterly Results;General 15-Feb-21
HAWAENG Quarterly Results 15-Feb-21 SUNRAJDI A.G.M.;Quarterly Results;General 15-Feb-21
HINDEVER Quarterly Results 15-Feb-21 TRANSFRE Quarterly Results 15-Feb-21
HITKITGLO Quarterly Results 15-Feb-21 VISVEN Quarterly Results 15-Feb-21
IRCON Bonus issue;Interim Dividend 15-Feb-21 VKAL Quarterly Results;General 15-Feb-21
JETAIRWAYS Audited Results 15-Feb-21 ADVENT Quarterly Results 16-Feb-21
JIKIND Quarterly Results;General 15-Feb-21 GMPL Interim Dividend;Quarterly Results 16-Feb-21
KERALAYUR Quarterly Results 15-Feb-21 GODREJPROP General 16-Feb-21
MIDESTI-B Quarterly Results 15-Feb-21 NESTLEIND Final Dividend;Audited Results 16-Feb-21

CORPORATE ACTION

Company Name Ex-Date Purpose Company Name Ex-Date Purpose
BALKRISIND 15-Feb-21 Interim Dividend – Rs. – 5.00 MINDAIND 15-Feb-21 Interim Dividend – Rs. – 0.3500
GALAXYSURF 15-Feb-21 Interim Dividend – Rs. – 14.00 PRAVEG 15-Feb-21 Interim Dividend – Rs. – 2.00
HEROMOTOCO 15-Feb-21 Interim Dividend – Rs. – 65.00 TORNTPHARM 15-Feb-21 Interim Dividend – Rs. – 20.00
HEROMOTOCO 15-Feb-21 Special Dividend – Rs. – 5.00 ACRYSIL 16-Feb-21 Interim Dividend – Rs. – 0.80
HIKAL 15-Feb-21 Interim Dividend – Rs. – 1.00 GPTINFRA 16-Feb-21 Interim Dividend – Rs. – 1.50
MINDACORP 15-Feb-21 Interim Dividend – Rs. – 0.30 GULFOILLUB 16-Feb-21 Interim Dividend – Rs. – 7.00

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.